Document/ExhibitDescriptionPagesSize 1: 8-K Current Report HTML 29K
2: EX-99.1 Miscellaneous Exhibit HTML 39K
7: R1 Cover Page HTML 52K
9: XML IDEA XML File -- Filing Summary XML 12K
12: XML XBRL Instance -- huma-20240229_htm XML 18K
8: EXCEL IDEA Workbook of Financial Report Info XLSX 8K
4: EX-101.DEF XBRL Definitions -- huma-20240229_def XML 41K
5: EX-101.LAB XBRL Labels -- huma-20240229_lab XML 85K
6: EX-101.PRE XBRL Presentations -- huma-20240229_pre XML 42K
3: EX-101.SCH XBRL Schema -- huma-20240229 XSD 11K
10: JSON XBRL Instance as JSON Data -- MetaLinks 14± 20K
11: ZIP XBRL Zipped Folder -- 0001818382-24-000019-xbrl Zip 33K
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
io
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
io
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
io
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
io
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
iCommon
Stock, par value $0.0001 per share
iHUMA
iThe Nasdaq Stock Market LLC
iRedeemable
Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
iHUMAW
iThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is
an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ix
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. io
Item
8.01. Other Events.
On February 29, 2024, Humacyte, Inc. (the “Company”) made available an investor presentation (the “Investor Presentation”), which the Company expects to use in connection with investor calls and/or conferences. A copy of the Investor Presentation is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
Cover Page
Interactive Data File (embedded within the Inline XBRL document).
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
